Washington Ranks 10th in Top 10 U.S. Biomedical & Pharma Clusters of 2024

Following Pfizer’s $43 billion acquisition of Seagen, the company shifted the construction of a $350 million manufacturing plant from Everett, WA, to Sanford, NC. Recent developments in Seattle’s South Lake Union include Alexandria Real Estate Equities resuming work on the 227,000-square-foot 701 Dexter Avenue North, set to open in 2025/26. Immunome has secured a new 29,344-square-foot headquarters in Bothell, with room for expansion.

Additionally, InduPro raised $85 million in Series A funding, and Vilya, a spinout from the University of Washington, completed a $71 million Series A round. Vertex expanded its kidney drug pipeline with the $4.9 billion acquisition of Alpine Immune Sciences, while Bruker acquired NanoString Technologies for $392.6 million.